REGULATORY
Prescribing of Torii’s Sublingual Cedar Pollinosis Treatment Cedartolen to be Restricted to Trained Doctors
The Pharmaceutical and Food Safety Bureau’s Evaluation and Licensing Division issued a notification to prefectures on January 17 regarding the use of Torii Pharmaceutical’s pollinosis treatment Cedartolen Sublingual Drop – Japanese Cedar Pollen 200 JAU/mL Bottle, 2,000 JAU/mL Bottle, 2,000…
To read the full story
Related Article
- Japan’s 1st Sublingual Immunotherapy Wins Approval: Torii
January 21, 2014
REGULATORY
- Japan to Ease Olanzapine Diabetes Contraindication for Antiemetic Use
July 31, 2026
- Pipe Damage Causes Water Leak at Sawai Plant after Quake: MHLW
July 30, 2026
- MHLW Urges Stable Supply of Drugs after Kumamoto Earthquake
July 30, 2026
- Kumamoto Quake Hits 46 Medical Facilities; No Pharma Damage Yet: MHLW
July 29, 2026
- Japan Shifts Mo-99 Supply Strategy toward Stronger Global Procurement: Panel
July 29, 2026
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…





